Multiple Myeloma-Clinicopathological Features and Risk Stratification

Authors

  • Mohsin Hussain Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Asad Mahmood Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Rafia Mahmood Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Hamid Iqbal Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Ayesha Khurshid Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
  • Nabeela Khan Armed Forces Institute of Pathology/National University of Medical Sciences (NUMS) Rawalpindi Pakistan

DOI:

https://doi.org/10.51253/pafmj.v72iSUPPL-2.3100

Keywords:

Anemia, Bone pain, Multiple myeloma, International myeloma working group, International staging system

Abstract

Objective: To evaluate the clinic pathological features and to risk stratify patients of multiple myeloma in our population.

Study Design: Cross sectional study.

Place and Duration of Study: Department of Hematology, Armed Forces Institute of Pathology (AFIP) Rawalpindi Pakistan, from Jan to Jun 2019.

Methodology: Patients that were newly diagnosed multiple myeloma on the basis of International Myeloma Working Group (IMWG) 2014 criteria were included in the study. Blood counts, peripheral film examination, bone marrow aspirate and trephine were examined. Biochemical profile, serum protein electrophoresis and skeletal survey was assessed.

Results: A total of 65 newly diagnosed Multiple Myeloma patients were included. Of these, 43 (66.2%) were males and 22 (33.8%) females. Mean age of the patients was 58.5 years with a range of 36-76 years. The most common presenting symptom was bone pain in 33 (50.8%) patients, followed by backache in 32 (49.2%) patients. Mean percentage of plasma cell on bone marrow examination was 40.89% ± 23.2. On risk stratification based on International staging system, 20 (30.7%) patients were in stage I, 19 (29.1%) patients were on stage II while 26 (40.2%) patients were in stage III.

Conclusion: Bone pain and backache along with anemia were found the predominant complaints of patients presenting with multiple myeloma in our setup with male predominance. Risk stratification of multiple myeloma according to ISS revealed that stage III was the most predominant in our population.

Downloads

Download data is not yet available.

Downloads

Published

31-05-2022

Issue

Section

Original Articles

How to Cite

1.
Hussain M, Mahmood A, Mahmood R, Iqbal H, Khurshid A, Khan N. Multiple Myeloma-Clinicopathological Features and Risk Stratification. Pak Armed Forces Med J [Internet]. 2022 May 31 [cited 2024 Jul. 19];72(SUPPL-2):S95-98. Available from: https://pafmj.org/PAFMJ/article/view/3100